An exploratory, randomized, parallel-group, open-label, relative bioavailability study with an additional two-period crossover food-effect study exploring the pharmacokinetics of two novel formulations of pexmetinib (ARRY-614)

Lance A Wollenberg1 Array BioPharma, Boulder, CO, USACorrespondence[email protected]

Donald T Corson2 Array BioPharma, Longmont, CO, USA;3 Avista Pharma Solutions, Longmont, CO, USA

Courtney A Nugent1 Array BioPharma, Boulder, CO, USA

Farran L Peterson1 Array BioPharma, Boulder, CO, USA

Ann M Ptaszynski1 Array BioPharma, Boulder, CO, USA

Alisha Arrigo2 Array BioPharma, Longmont, CO, USA;3 Avista Pharma Solutions, Longmont, CO, USA

Coralee G Mannila2 Array BioPharma, Longmont, CO, USA;3 Avista Pharma Solutions, Longmont, CO, USA

Kevin S Litwiler1 Array BioPharma, Boulder, CO, USA

Stacie J Bell1 Array BioPharma, Boulder, CO, USA;4 Mallinckrodt Pharmaceuticals, Ellicott City, MD, USA

References